Evidence map›Paper›PMID 37033841›Full record

ReviewACS omega2023

Trends in Research and Development for CO

Xiang Yu, Carmen Otilia Catanescu, Robert E Bird, Sriram Satagopan, Zachary J Baum, Leilani M Lotti Diaz, Qiongqiong Angela Zhou

Open access · goldAbstract readReview
In one paragraph

Review in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 100 citations in OpenAlex.

  1. COACS omega · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Comparative Analysis of COMolecules (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Enhanced COLangmuir : the ACS journal of surfaces and colloids · 2024
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiang YuCAS, a division of the American Chemical Society 2540 Olentangy River Rd., Columbus, Ohio 43202, United States.ORCID https://orcid.org/0000-0002-3846-9969
Carmen Otilia CatanescuCAS, a division of the American Chemical Society 2540 Olentangy River Rd., Columbus, Ohio 43202, United States.ORCID https://orcid.org/0000-0002-9392-4784
Robert E BirdCAS, a division of the American Chemical Society 2540 Olentangy River Rd., Columbus, Ohio 43202, United States.ORCID https://orcid.org/0000-0001-6965-975X
Sriram SatagopanCAS, a division of the American Chemical Society 2540 Olentangy River Rd., Columbus, Ohio 43202, United States.ORCID https://orcid.org/0000-0002-4867-531X
Zachary J BaumCAS, a division of the American Chemical Society 2540 Olentangy River Rd., Columbus, Ohio 43202, United States.ORCID https://orcid.org/0000-0002-0585-8503
Leilani M Lotti DiazCAS, a division of the American Chemical Society 2540 Olentangy River Rd., Columbus, Ohio 43202, United States.ORCID https://orcid.org/0000-0001-5955-9595
Qiongqiong Angela ZhouCAS, a division of the American Chemical Society 2540 Olentangy River Rd., Columbus, Ohio 43202, United States.ORCID https://orcid.org/0000-0001-6711-369X
American Chemical Society · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Technological and medical advances over the past few decades epitomize human capabilities. However, the increased life expectancies and concomitant land-use changes have significantly contributed to the release of ∼830 gigatons of CO

Identifiers

PMID37033841
PMCPMC10077574
OpenAlexW4360610963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.